99mTc-QULIC-5-P1 SPECT Imaging in Patients With Prostate Cancer

EARLY_PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 20, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions

Prostate Cancer StagePSMASPECT

Interventions

DRUG

99mTc-QULIC-5-P1

Each subject receives a single intravenous injection of 99mTc-QULIC-5-P1.

Trial Locations (1)

RECRUITING

The First Affiliated Hospital of Chongqing Medical University, Chongqing

All Listed Sponsors

lead

First Affiliated Hospital of Chongqing Medical University

OTHER